Amy L. Burroughs, Chief Executive Officer at Terns Pharmaceuticals, Inc. (TERN), sold 142,678 shares at $38.10 ($5.4M) on 2026-01-05, disclosed to the SEC on 2026-01-06.
Open-market sale of $5.4M TERN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.10 | 71,339 | $2.7M | 50.0% |
| 2 | $38.10 | 71,339 | $2.7M | 50.0% |
| Total | $38.10 avg | 142,678 | $5.4M | 100% |
| Filing → |
| TERN | SELL | 2026-01-16 | $5.1M | — | Filing → |
| TERN | BUY | 2025-06-25 | $180K | — | Filing → |
| TERN | BUY | 2025-02-03 | $3K | — | Filing → |